207 results
Posted on 16.06.2009
Treating Osteoarthritis: will new research lead to a “run” of success?
On Thursday 11 June, I attended, as part of the EULAR conference in Copenhagen – Europe’s largest conference on Rheumatology – the session “Structure modification in osteoarthritis: Time to update the guidelines”. What became really apparent was that rheumatologists from Europe and North-America are seriously concerned about the exponentially increasing prevalence and incidence of osteoarthritis […]
Posted on 29.05.2009
2009 Hauptstadtkongress debates affordability of innovation for the German healthcare system
Is innovation still affordable with increasingly strained healthcare budgets? How can medical innovations continued to be financed? Panelist of the round table of distinguished speakers Member of the European Parliament Jorgo Chatzimarkakis made a statement which nicely complements the study released by AdvaMed only 2 days ago. He said that innovation does not increase costs […]
Posted on 28.05.2009
From the Haupstadtkongress – Patient safety, what can be done on a European level?
Listening to a distinguished panel of experts chaired by Bernard Merkel of DG Sanco I get the impression that things are moving to raise the level of patient safety. I was interested to learn that DG Sanco has commissioned a study to rate Member States in their efforts to combat patient safety. This “black list” […]
Heat and quite a lot of light
The sweltering heat and fever pitch of the football supporters contrasts starkly with the measured debate at the 2009 International Medical Device Industry Compliance, Regulatory and Intellectual Property Conference here in Rome. The Champions League final sees football shirted supporters rubbing shoulders with suited captains of industry in an unlikely melange. One item of news […]
Posted on 06.05.2009
MassMEDIC Annual Meeting: Reflections on industry clinician collaboration
Sitting on Boston’s south shore, the John F. Kennedy Pesidential Library is both imposing yet not over-stated. A rare treat for me was the opportunity to address the annual meeting of MassMEDIC, the largest regional medical technology association in the USA – and that means the world, I am sure! The speaker’s podium has a […]
Eucomed press release 05/09 – Revised Directive on Late payments: 23.6 billion Euros of unpaid invoices threaten small companies’ survival and jeopardize public health
Brussels, 8 April 2009 – Eucomed welcomes revision of directive 2000/35/EC on Late Payments adopted by the European Commission today strengthening current payment obligations. Association disappointed to see final text considerably watered down compared to initial clear targets. As the voice of the medical technology industry in Europe, Eucomed is extremely pleased to see late […]
More from the DIA EuroMeeting 2009
From 23 – 25 March 2009, the Drug Information Association (DIA) held its annual EuroMeeting in Berlin. During the presentation by Richard Moore, Institute of Nanotechnology, I learned that prescription drugs prove to be ineffective in 30% – 60% of patients1 and that 16% of the drugs approved in the USA are linked to severe […]
The role of EMEA in future regulation: consensus amongst experts
It was with some trepidation that I placed myself in the ‘lions den’ of the pharmaceutical industry at the annual Euromeeting of the Drug Information Association in Berlin today. Sharing a platform to discuss the evolution of medical device regulation with Mdme Georgette Lalis of the EU Commission and David Feigal, former FDA Commissioner, proved […]
Welcome to the Eucomed blog…
Hello and welcome to the Eucomed blog. This is the place to find out about the latest news on all aspects of medical technology, from financing of healthcare to European regulation. You will also be able to read short reports of events attended by Eucomed staff. We have put together a team of bloggers, each […]